| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 163.505 | 214.514 | 233.548 | 162.156 | 222.208 | 254.391 |
| Total Income - EUR | - | - | - | 1.341 | 165.093 | 214.514 | 234.003 | 167.175 | 222.208 | 254.391 |
| Total Expenses - EUR | - | - | - | 12.969 | 163.021 | 199.234 | 223.104 | 210.068 | 222.183 | 233.581 |
| Gross Profit/Loss - EUR | - | - | - | -11.628 | 2.072 | 15.280 | 10.900 | -42.893 | 25 | 20.810 |
| Net Profit/Loss - EUR | - | - | - | -11.668 | 421 | 13.184 | 8.844 | -44.514 | -2.197 | 17.480 |
| Employees | - | - | - | 0 | 2 | 3 | 4 | 4 | 3 | 3 |
Check the financial reports for the company - Tarbus Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 8.727 | 25.408 | 221.327 | 187.939 | 159.958 | 131.700 | 103.287 |
| Current Assets | - | - | - | 23.913 | 9.912 | 25.621 | 20.703 | 3.804 | 8.721 | 61.906 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 2.041 | 0 | 22.805 | 20.127 | 1.930 | 7.444 | 8.393 |
| Cash | - | - | - | 21.871 | 9.912 | 2.816 | 576 | 1.873 | 1.277 | 53.513 |
| Shareholders Funds | - | - | - | -9.519 | -8.913 | 4.440 | 13.185 | -31.288 | -33.390 | -15.724 |
| Social Capital | - | - | - | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | 42.159 | 44.233 | 242.507 | 195.457 | 195.049 | 173.811 | 180.917 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tarbus Medical S.r.l.